Correlation Between Principal Lifetime and Pharmaceuticals Ultrasector

Can any of the company-specific risk be diversified away by investing in both Principal Lifetime and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Principal Lifetime and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Principal Lifetime Hybrid and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Principal Lifetime and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Principal Lifetime with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Principal Lifetime and Pharmaceuticals Ultrasector.

Diversification Opportunities for Principal Lifetime and Pharmaceuticals Ultrasector

0.8

Correlation Coefficient

Principal Lifetime  Pharmaceuticals Ultrasector

Very poor diversification

The 3 months correlation between PRINCIPAL and Pharmaceuticals is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Principal Lifetime Hybrid and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Principal Lifetime is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Principal Lifetime Hybrid are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Principal Lifetime i.e., Principal Lifetime and Pharmaceuticals Ultrasector go up and down completely randomly.

Pair Corralation between Principal Lifetime and Pharmaceuticals Ultrasector

Assuming the 90 days horizon Principal Lifetime Hybrid is expected to generate 0.5 times more return on investment than Pharmaceuticals Ultrasector. However, Principal Lifetime Hybrid is 1.99 times less risky than Pharmaceuticals Ultrasector. It trades about -0.03 of its potential returns per unit of risk. Pharmaceuticals Ultrasector Profund is currently generating about -0.06 per unit of risk. If you would invest  1,780  in Principal Lifetime Hybrid on December 2, 2024 and sell it today you would lose (32.00) from holding Principal Lifetime Hybrid or give up 1.8% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Principal Lifetime Hybrid  vs.  Pharmaceuticals Ultrasector Pr

Principal Lifetime Hybrid

Risk-Adjusted Performance

Very Weak

Over the last 90 days Principal Lifetime Hybrid has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Principal Lifetime is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharmaceuticals Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Pharmaceuticals Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Principal Lifetime and Pharmaceuticals Ultrasector

The main advantage of trading using opposite Principal Lifetime and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Principal Lifetime position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.

The idea behind Principal Lifetime Hybrid and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.